CBD, the short name for cannabidiol,
remains a hot topic today in the consumer and investment spaces. Companies are packing the component of hemp
and cannabis touted for its powerful positive benefits into a litany of
products, ranging from creams to gummies to medicines to food and beverages and
everywhere in between. Why? Because consumer demand is soaring and the
recent passage of the Farm Bill made hemp-derived CBD completely legal, opening
up interstate commerce without fears of prosecution.
CBD, which doesn’t contain any of the
psychoactive components that result in the “high” frequently associated with
cannabis, has a therapeutic index that goes from alleviating symptoms of
hard-to-treat diseases like epilepsy to anti-aging skin properties.
This segment of the so-called “green rush”
– used to describe cannabis reform sweeping the planet – could be growing
faster than the legal marijuana market.
Owing to increased consumer awareness about CBD’s uses and safety
profile and relaxed hemp regulations, industry analysts at the Brightfield
Group forecast that the hemp-derived CBD market could swell to $22
billion by 2022 from about $580 million in 2018.
At Quanta, Inc. (OTC: QNTA), scientists
are using quantum physics to manipulate and stabilize electron spin in
naturally occurring elements, including CBD, to increase performance in the
body. The result is CBD that is
“polarized,” which brings with it a bevy of benefits that essentially amplify
the properties of CBD in a consistent and repeatable fashion. This means products using polarized CBD are
faster acting with stronger healing power that last longer without making a
person tired compared to competitor’s products.
Many companies tout increased
“bioavailability,” meaning that the active ingredient in their product reaches
its target in a more efficient way.
Others have trumpeted innovation in increasing bioenergy (or
bio-activity), increasing the physical energy and effectiveness of any
percentage of CBD available.
Burbank, California-based Quanta takes it a
step further, saying that its technology is the first to “increase and sustain”
bio-activity in CBD. The applied science
company’s flagship product is a muscle rub, a combination of 13 natural
ingredients, including, but not limited to, CBD, arnica, turmeric, ginger and
sunflower oil. Aptly branded as “Quanta
CBD Muscle Rub,” the proprietary blend of the ingredients maximizes
anti-inflammatory relief and circulation while easing aches and pains in
muscles and joints for comfort and overall well-being.
Quanta also sells an ultra-premium CBD vape
cartridge containing hemp-derived CBD.
According to Quanta, sales of the premium
organic rub are improving dramatically since the initial launch just over five
months ago. The company sells the balm
through its ecommerce channels in addition to being available in more than 300
doctor’s offices, 100 pharmacies and over 150 retail shops.
Quanta CEO Eric Rice didn’t provide
specifics, but did say earlier this month that the muscle rub has built a loyal
customer base that has helped bolster sales 70%
month-over-month since launch.
Rice added that they are working on adding
more distribution partners, including ongoing discussions with several national
fitness centers, hospital networks and pain management centers. The company is also planning to add more
products to the portfolio using its polarization technology, for which it will manufacture
its own line of CBD products in-house.
The company made the shift in business model from licensing CBD brands
to the more lucrative model of manufacturing its own products subsequent to the
passing of the Farm Bill.
Online Media Group, Inc. is not registered
with any financial or securities regulatory authority and holds no investment
licenses and does not provide, nor claims to provide, investment advice. We are
a publisher of original and third-party news and information. This article is
sponsored content and is neither an offer nor recommendation to buy, sell or
hold any security. The views expressed are our own and not intended to be the
basis for any investment decision. Investing intrinsically involves substantial
risk and readers are reminded to consult an investment professional and
complete their own due diligence, including SEC filings, when researching any
companies mentioned in this release. This release is based upon publicly
available information and, while vetted, is not considered to be all-inclusive
or guaranteed to be free from errors. With respect to Section 17(B) of the
Securities Act of 1933 and in the interest of full disclosure, we call the
reader’s attention to the fact that Online Media Group, Inc. received $1,333 in
compensation from a third-party for content creation, advertising and
distribution services related to this material.